5 news items
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
ATXI
FBIO
16 May 24
This press release contains predictive or "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
ATXI
FBIO
15 May 24
" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ADXN
ALT
ALTM
29 Apr 24
climbed 35.5% to $28.56 after the company announced $1.1 billion settlement for Respironics personal injury and medical monitoring litigation
Avenue Therapeutics Announces Reverse Stock Split
ATXI
FBIO
24 Apr 24
the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
ATXI
FBIO
25 Mar 24
Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this press release, including
- Prev
- 1
- Next